DSpace Repository

CELIAC DISEASE IN JUVENILE IDIOPATHIC ARTHRITIS AND OTHER PEDIATRIC RHEUMATIC DISORDERS

Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.

Show simple item record

dc.contributor.author Poddighe, Dimitri
dc.contributor.author Romano, Micol
dc.contributor.author Dossybayeva, Kuanysh
dc.contributor.author Abdukhakimova, Diyora
dc.contributor.author Galiyeva, Dinara
dc.contributor.author Demirkaya, Erkan
dc.date.accessioned 2023-04-21T10:05:14Z
dc.date.available 2023-04-21T10:05:14Z
dc.date.issued 2022
dc.identifier.citation Poddighe, D., Romano, M., Dossybayeva, K., Abdukhakimova, D., Galiyeva, D., & Demirkaya, E. (2022). Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders. Journal of Clinical Medicine, 11(4), 1089. https://doi.org/10.3390/jcm11041089 en_US
dc.identifier.uri http://nur.nu.edu.kz/handle/123456789/7036
dc.description.abstract Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic disorders, there is no clear recommendation for CD serological screening. In this review, we analyze all the available clinical studies investigating CD among children with JIA (and other rheumatic diseases), in order to provide objective data to better understand the necessity of CD serological screening during the follow-up. Based on the present literature review and analysis, >2.5% patients with JIA were diagnosed with CD; however, the CD prevalence in JIA patients may be even higher (>3–3.5%) due to several study limitations that could have underestimated CD diagnosis to a variable extent. Therefore, serological screening for CD in children affected with JIA could be recommended due to the increased CD prevalence in these patients (compared to the general pediatric population), and because these JIA patients diagnosed with CD were mostly asymptomatic. However, further research is needed to establish a cost-effective approach in terms of CD screening frequency and modalities during the follow-up for JIA patients. Conversely, at the moment, there is no evidence supporting a periodical CD screening in children affected with other rheumatic diseases (including pediatric systemic lupus erythematosus, juvenile dermatomyositis, and systemic sclerosis). en_US
dc.language.iso en en_US
dc.publisher Journal of Clinical Medicine en_US
dc.rights Attribution-NonCommercial-ShareAlike 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/us/ *
dc.subject Type of access: Open Access en_US
dc.subject celiac disease en_US
dc.subject juvenile idiopathic arthritis en_US
dc.subject pediatric systemic lupus erythematosus en_US
dc.subject juvenile dermatomyositis en_US
dc.subject systemic scleroderma en_US
dc.subject screening en_US
dc.subject prevalence en_US
dc.title CELIAC DISEASE IN JUVENILE IDIOPATHIC ARTHRITIS AND OTHER PEDIATRIC RHEUMATIC DISORDERS en_US
dc.type Article en_US
workflow.import.source science


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States